Turnstone is developing a differentiated approach to treat solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy

ID: 989891140055859201

linkhttps://turnstonebio.com/ calendar_today27-04-2018 15:36:53